ACAD
27.32
-0.47
-1.69%
AEMD
4.64
-0.03
-0.64%
APRI
1.32
+0.03
+2.33%
ARNA
1.43
-0.02
-1.38%
ATEC
4.99
-0.09
-1.77%
CNAT
1.93
+0.05
+2.6543%
CRXM
0.16
-0.01
-5.83%
CYTX
1.55
-0.01
-0.64%
DXCM
65
+0.55
+0.85%
GNMK
11.02
-0.32
-2.82%
HALO
11.445
-0.375
-3.173%
ILMN
126.18
-1.74
-1.36%
INNV
0.261
+0.003
+1.15892%
INO
7.06
-0.02
-0.28%
ISCO
1.2
+0.05
+4.35%
ISIS
0
0.00
0.00%
LGND
105.24
-1.27
-1.19%
LPTN
2.67
-0.046
-1.6972%
MBVX
4.07
-0.05
-1.21%
MEIP
1.55
-0.05
-3.13%
MNOV
7.64
+0.43
+5.96%
MRTX
5.075
-0.075
-1.456%
MSTX
0.083
-0.001
-0.9512%
NBIX
43.64
+0.03
+0.07%
NUVA
65.98
+0.12
+0.18%
ONCS
1.31
-0.05
-3.68%
ONVO
3.034
-0.066
-2.1419%
OREX
1.86
-0.04
-2.11%
OTIC
15.5
+0.35
+2.31%
QDEL
22.01
-0.01
-0.05%
RCPT
0
0.00
0.00%
RGLS
2.575
-0.275
-9.649%
RMD
59.06
-0.87
-1.45%
SCIE
0.002
+0.001
+35.7143%
SPHS
2.74
-0.06
-2.14%
SRNE
5.25
-0.05
-0.94%
TROV
2.45
-0.05
-2.00%
VICL
2.31
+0.01
+0.43%
ZGNX
13.1
+0.4
+3.15%
ACAD
27.32
-0.47
-1.69%
AEMD
4.64
-0.03
-0.64%
APRI
1.32
+0.03
+2.33%
ARNA
1.43
-0.02
-1.38%
ATEC
4.99
-0.09
-1.77%
CNAT
1.93
+0.05
+2.6543%
CRXM
0.16
-0.01
-5.83%
CYTX
1.55
-0.01
-0.64%
DXCM
65
+0.55
+0.85%
GNMK
11.02
-0.32
-2.82%
HALO
11.445
-0.375
-3.173%
ILMN
126.18
-1.74
-1.36%
INNV
0.261
+0.003
+1.15892%
INO
7.06
-0.02
-0.28%
ISCO
1.2
+0.05
+4.35%
ISIS
0
0.00
0.00%
LGND
105.24
-1.27
-1.19%
LPTN
2.67
-0.046
-1.6972%
MBVX
4.07
-0.05
-1.21%
MEIP
1.55
-0.05
-3.13%
MNOV
7.64
+0.43
+5.96%
MRTX
5.075
-0.075
-1.456%
MSTX
0.083
-0.001
-0.9512%
NBIX
43.64
+0.03
+0.07%
NUVA
65.98
+0.12
+0.18%
ONCS
1.31
-0.05
-3.68%
ONVO
3.034
-0.066
-2.1419%
OREX
1.86
-0.04
-2.11%
OTIC
15.5
+0.35
+2.31%
QDEL
22.01
-0.01
-0.05%
RCPT
0
0.00
0.00%
RGLS
2.575
-0.275
-9.649%
RMD
59.06
-0.87
-1.45%
SCIE
0.002
+0.001
+35.7143%
SPHS
2.74
-0.06
-2.14%
SRNE
5.25
-0.05
-0.94%
TROV
2.45
-0.05
-2.00%
VICL
2.31
+0.01
+0.43%
ZGNX
13.1
+0.4
+3.15%
Home » Archive by Category

Xconomy

With Biogen at a Crossroads, CEO Scangos to Step Down

July 21, 2016 – 5:19 am

[Updated, 9:20 a.m. ET, see below] Biogen has seen its highest highs under CEO George Scangos, but some lows too. After a year in which Biogen’s share price has fallen by more than a third and one of…

[[Click headline to continue reading.]]

Dauntless Takes Flight with New Business Model for Starting Biotechs

July 20, 2016 – 10:43 pm

First came Inception Sciences, a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. Then came COI…

[[Click headline to continue reading.]]

Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval

July 20, 2016 – 5:26 am

As the possibility of the first ever gene therapy approval in the U.S. draws closer, more gene therapy players are entering the public markets. Today, it’s San Francisco’s Audentes Therapeutics,…

[[Click headline to continue reading.]]

Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics

July 19, 2016 – 9:00 pm

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by…

[[Click headline to continue reading.]]

Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure

July 18, 2016 – 8:30 am

Evoke Pharma is taking a hit in the markets after announcing a Phase 3 trial on a gastroinetestinal drug for diabetes patients failed to meet its goals. In early trading Monday, Evoke’s (NASDAQ:…

[[Click headline to continue reading.]]

The Pan-Cancer Screen: Still Early for Prime Time

July 18, 2016 – 6:19 am

Imagine you could go to your doctor once a year for a blood test that would detect nearly every common type of cancer at an early stage. If you had a positive result, some further testing could…

[[Click headline to continue reading.]]

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

July 15, 2016 – 4:00 am

The week started on a reflective note. Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. And then the…

[[Click headline to continue reading.]]

An Homage to Larry Bock, Who Had God’s Hand on His Shoulder

July 10, 2016 – 10:40 pm

When I told Larry Bock in an e-mail about four months ago that I had been diagnosed with cancer, the renowned San Diego life sciences investor asked if he might see me at UC San Diego’s Moores…

[[Click headline to continue reading.]]

Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More

July 8, 2016 – 3:30 am

This week started with celebrations of America’s birthday, and it has been dominated—biotech-wise—by America’s government. The Obama administration continued its high-profile…

[[Click headline to continue reading.]]

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

July 7, 2016 – 7:23 am

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. Morristown, NJ-based…

[[Click headline to continue reading.]]